Results 221 to 230 of about 44,035 (314)

Clinical Characteristics and Risk Factors for Cutaneous Manifestations Associated With Nemolizumab in Atopic Dermatitis: A Multicenter Retrospective Study in Japan

The Journal of Dermatology, Volume 53, Issue 3, Page 399-409, March 2026.
ABSTRACT Nemolizumab, an anti‐interleukin‐31 receptor A monoclonal antibody, has been approved in Japan for treating atopic dermatitis (AD)‐associated pruritus. While it is effective for itch control, nemolizumab‐associated cutaneous adverse events have been increasingly recognized, yet their clinical features remain poorly characterized. In this study,
Wataru Sasaki, Ryo Saito, Kenta Suzuki, Daisuke Watanabe, Masako Minami‐Hori, Hirofumi Kamada, Hiroo Amano, Akihiko Uchiyama, Sei‐ichiro Motegi, Machiko Kamura, Kazunari Sugita, Noriko Kubota, Toshifumi Nomura, Maki Ozawa, Toshiya Takahashi, Takashi Yamakita, Kazumitsu Sugiura, Tetsuharu Ikegami, Ken Igawa, Yuka Kimura, Yoko Kataoka, Ryoichi Kamide, Masakazu Takahashi, Akio Tanaka, Mariko Sugawara‐Mikami   +24 more
wiley   +1 more source

Endogenous treatments for migraine pain. [PDF]

J Headache Pain
Della Pietra A, Russo AF.
europepmc   +1 more source

Group Experiments on the Radioimmunological Insulin Determination [PDF]

, 1974
Bottermann, P., Erhardt, F., Linke, R., Löffler, G., Maier, V., Marschner, I., Schwandt, P., Scriba, Peter Christian, Vogt, W.   +8 more
core   +1 more source

Development of a High‐Risk Medication List for Australian Residential Aged Care: A Modified Delphi Study

Australasian Journal on Ageing, Volume 45, Issue 1, March 2026.
ABSTRACT Introduction High‐risk medications are medications associated with significant patient harm or death if misused or used in error. This study aimed to develop a national consensus high‐risk medication list for use in Australian residential aged care.
Amanda J. Cross, Madiha Chaudhry, Darshna Goordeen, Juanita L. Breen, Malcolm Clark, Stephanie Daly, Belinda Delardes, Bente Hart, Deborah Hawthorne, Peter J. Hayball, Sarah N. Hilmer, Lisa Kouladjian O’Donnell, MaryAnn Kulh, Kenneth Lee, David F. L. Liew, Stephen Macfarlane, Elizabeth Manias, Anthony Marinucci, Constance Dimity Pond, Helen Rawson, Susan Slatyer, Andrew Stafford, Amy B. Thomson, Kate Wang, Kirolos Wasef, Jonathan Zimmerman, Nadine E. Andrew, Gauri P. Godbole, Louise Lord, Atish Manek, Brigid McInerney, Michelle Steeper, Justin P. Turner, J. Simon Bell   +33 more
wiley   +1 more source

The significance of endocannabinoid receptors and endocannabinoids in the lower urinary and genital tract. [PDF]

World J Urol
Ückert S, Hedlund P, Tsikas D, Kuczyk MA.   +3 more
europepmc   +1 more source

The sensory penis: A comprehensive immunohistological and ontogenetic exploration of human penile innervation

Andrology, Volume 14, Issue 3, Page 661-701, March 2026.
Abstract Background Penile sexual sensation relies on intricate neural structures that remain incompletely characterized. Immunohistological insights into their development and organization can enhance understanding of penile neuroanatomy and function, while optimizing surgical outcomes.
Alfonso Cepeda‐Emiliani, María Otero‐Alén, Juan Suárez‐Quintanilla, Marina Gándara‐Cortés, Tomás García‐Caballero, Rosalía Gallego, Lucía García‐Caballero   +6 more
wiley   +1 more source

Human DRG Glucocorticoid Receptor Profiling Reveals Targets for Regionally Delivered Steroid Analgesia. [PDF]

Cells
Mousa SA, Metwally EY, Li X, Tafelski S, Retana Romero OA, Piontek J, Treskatsch S, Schäfer M, Shaqura M.   +8 more
europepmc   +1 more source

Surgical Interventions in Idiopathic Intracranial Hypertension—A Comprehensive Multi‐Center Study of Outcome and the Role of Treatment Indication

European Journal of Neurology, Volume 33, Issue 3, March 2026.
In this multicenter retrospective study of idiopathic intracranial hypertension, only 3.6% of patients required surgery, predominantly for acute visual deterioration. Both cerebrospinal fluid diversion and optic nerve sheath fenestration were effective in improving visual outcomes and resolving papilledema, while headache improvement was limited ...
Gabriel Bsteh, Nadja Skadkær Hansen, Sina Zaic, Steffen Hamann, Johanne Juhl Korsbæk, Nik Krajnc, Stefan Macher, Laleh Dehghani Molander, Klaus Novak, Therese Wallentin Steenfos, Marianne Wegener, Berthold Pemp, Rigmor Højland Jensen, Dagmar Beier, Kaare Fugleholm, Marianne Juhler, Karl Kirchner, Martin Michl, Christoph Mitsch, Nina Müller, Petersen Bibi Gronemann, Andreas Reitner, Christoph Stapf, Christian Wöber, Karin Zebenholzer   +24 more
wiley   +1 more source

Trigeminal nerve-driven neurogenic inflammation linking migraine to glioblastoma invasion: a literature review. [PDF]

Front Immunol
Song X, Zhu Q, Zhang J, Yang J, Zhang X, Song Q.   +5 more
europepmc   +1 more source

A Real‐World Study of CGRP Monoclonal Antibodies for Migraine: Long‐Term Effectiveness and Treatment Adherence

European Journal of Neurology, Volume 33, Issue 3, March 2026.
In our 24‐month real‐world study, the mean monthly migraine days (MMDs) significantly decreased from baseline by 6.8, 7.9, 8.7, and 10.0 days at Months 3, 6, 12, and 24, respectively (all p < 0.001). Significant reductions were also observed across all time points in both episodic migraine and chronic migraine subgroups.
Keisuke Suzuki, Shiho Suzuki, Saro Kobayashi, Mukuto Shioda, Hiroaki Fujita, Yasuo Haruyama, Koichi Hirata   +6 more
wiley   +1 more source